ESC 365 - Tolerability and safety of Sacubitril/Valsartan in real-life practice

HFA Premium Access

Tolerability and safety of Sacubitril/Valsartan in real-life practice

Session: Poster Session 1 - Chronic Heart Failure – Treatment

Topic: Pharmacotherapy

Speaker: Doctor J. Neiva (Viana do Castelo, PT)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Doctor Joana Neiva

ULSAM - Hospital de Santa Luzia, Viana do Castelo (Portugal)

0 follower

67 more presentations in this session

Combined therapy with ACEI/ARB, beta-blocker, statin, antithrombotic drug and cardiovascular mortality in comorbide patients with heart failure, coronary artery disease, arterial hypertension

Heart failure over 19 years: are we on the right way?

B-blockers and prognosis in cardiac amyloidosis

Speaker: Doctor E. Repasos (Athens, GR)

Safety and efficacy of valsartan-sacubitril in a cohort of patients with symptomatic heart failure receiving small doses of ACE

Speaker: Doctor A. Ntalianis (Athens, GR)

Barriers and motivations to physical activity in heart failure patients; is a specific approach needed for women?

Speaker: Professor T. Jaarsma (Linkoping, SE)

Access the full session

Poster Session 1 - Chronic Heart Failure – Treatment

Speakers: Doctor J. Neiva, Doctor E. Repasos, Doctor A. Ntalianis, Professor T. Jaarsma

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources